Ajai Chari
United States
Ajai Chari
United States
Expert bio
Dr Chari completed his medical degree at the UCLA School of Medicine. His clinical focus is on patients with multiple myeloma and other plasma cell disorders, and he has also published and lectured extensively on topics relating to these diseases. Dr Chari is involved in several clinical trials investigating new drug regimens, and he oversees a program that played a pivotal role in the approval of the five newest drugs used for the treatment of multiple myeloma.
Dr Chari is Professor of Medicine, Director of Clinical Research in the Multiple Myeloma Program, and Associate Director of Clinical Research at the Mount Sinai Cancer Clinical Trials Office in New York, New York, USA.
EM-70864 - Date of preparation: August 2021